Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Hepatocellular carcinoma: epidemiology, screening, and assessment of hepatic reserve.

Literature DB >> 33343207

Hepatocellular carcinoma: epidemiology, screening, and assessment of hepatic reserve.

Abstract

Hepatocellular carcinoma is a leading cause of cancer-related mortality worldwide. This review summarizes the epidemiology and causes of the disease, and the roles of screening and surveillance for early tumour detection. It also highlights the important role of assessment of hepatic reserve in consideration of appropriate staging and treatment. 2020 Multimed Inc.

Entities: Disease

Keywords: Hepatocellular carcinoma; epidemiology; risk factors; screening; surveillance

Year: 2020 PMID： 33343207 PMCID： PMC7739519 DOI： 10.3747/co.27.7181

Source DB: PubMed Journal: Curr Oncol ISSN： 1198-0052 Impact factor: 3.677

52 in total

1. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group.

Authors: M H Chang; C J Chen; M S Lai; H M Hsu; T C Wu; M S Kong; D C Liang; W Y Shau; D S Chen
Journal: N Engl J Med Date: 1997-06-26 Impact factor: 91.245

Review 2. Global epidemiology of hepatocellular carcinoma: an emphasis on demographic and regional variability.

Authors: Katherine A McGlynn; Jessica L Petrick; W Thomas London
Journal: Clin Liver Dis Date: 2015-02-26 Impact factor: 6.126

Review 3. Nucleos(t)ide analogs in the prevention of hepatitis B virus related hepatocellular carcinoma.

Authors: Bulent Baran
Journal: World J Hepatol Date: 2015-07-08

4. Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade.

Authors: Philip J Johnson; Sarah Berhane; Chiaki Kagebayashi; Shinji Satomura; Mabel Teng; Helen L Reeves; James O'Beirne; Richard Fox; Anna Skowronska; Daniel Palmer; Winnie Yeo; Frankie Mo; Paul Lai; Mercedes Iñarrairaegui; Stephen L Chan; Bruno Sangro; Rebecca Miksad; Toshifumi Tada; Takashi Kumada; Hidenori Toyoda
Journal: J Clin Oncol Date: 2014-12-15 Impact factor: 44.544

Review 5. Epidemiology of hepatocellular carcinoma: target population for surveillance and diagnosis.

Authors: An Tang; Oussama Hallouch; Victoria Chernyak; Aya Kamaya; Claude B Sirlin
Journal: Abdom Radiol (NY) Date: 2018-01

Review 6. Evidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma.

Authors: Jordi Bruix; Maria Reig; Morris Sherman
Journal: Gastroenterology Date: 2016-01-12 Impact factor: 22.682

7. Randomized controlled trial of screening for hepatocellular carcinoma.

Authors: Bo-Heng Zhang; Bing-Hui Yang; Zhao-You Tang
Journal: J Cancer Res Clin Oncol Date: 2004-07 Impact factor: 4.553

Review 8. A global view of hepatocellular carcinoma: trends, risk, prevention and management.

Authors: Ju Dong Yang; Pierre Hainaut; Gregory J Gores; Amina Amadou; Amelie Plymoth; Lewis R Roberts
Journal: Nat Rev Gastroenterol Hepatol Date: 2019-08-22 Impact factor: 73.082

Review 9. Epidemiology of Hepatocellular Carcinoma.

Authors: Katherine A McGlynn; Jessica L Petrick; Hashem B El-Serag
Journal: Hepatology Date: 2020-11-24 Impact factor: 17.298

10. Early detection, curative treatment, and survival rates for hepatocellular carcinoma surveillance in patients with cirrhosis: a meta-analysis.

Authors: Amit G Singal; Anjana Pillai; Jasmin Tiro
Journal: PLoS Med Date: 2014-04-01 Impact factor: 11.069

5 in total

Review 1. Recent Advances in Anticancer Activity of Novel Plant Extracts and Compounds from Curcuma longa in Hepatocellular Carcinoma.

Authors: Nighat Gull; Fareeha Arshad; Gowhar A Naikoo; Israr Ul Hassan; Mona Zamani Pedram; Arif Ahmad; Alaa A A Aljabali; Vijay Mishra; Saurabh Satija; Nitin Charbe; Poonam Negi; Rohit Goyal; Ángel Serrano-Aroca; Mazhar S Al Zoubi; Mohamed El-Tanani; Murtaza M Tambuwala
Journal: J Gastrointest Cancer Date: 2022-03-14

2. The novel circular RNA HIPK3 accelerates the proliferation and invasion of hepatocellular carcinoma cells by sponging the micro RNA-124 or micro RNA-506/pyruvate dehydrogenase kinase 2 axis.

Authors: Qiangfeng Yu; Wenxiang Chen; Yiming Li; Jun He; Yu Wang; Sijia Yang; Jianyin Zhou
Journal: Bioengineered Date: 2022-03 Impact factor: 3.269

3. The Oncogenic and Diagnostic Potential of Stanniocalcin 2 in Hepatocellular Carcinoma.

Authors: Zhixian Wu; Hongwei Cheng; Jie Liu; Shuaishuai Zhang; Minda Zhang; Fangzhou Liu; Yinghui Li; Qian Huang; Yi Jiang; Shaohua Chen; Lizhi Lv; Dongliang Li; Jin-Zhang Zeng
Journal: J Hepatocell Carcinoma Date: 2022-03-08

Review 4. Molecular pathogenesis: Connections between viral hepatitis-induced and non-alcoholic steatohepatitis-induced hepatocellular carcinoma.

Authors: Zelin Tian; Chen Xu; Peijun Yang; Zhibin Lin; Wenlong Wu; Wenjie Zhang; Jian Ding; Rui Ding; Xuan Zhang; Kefeng Dou
Journal: Front Immunol Date: 2022-09-15 Impact factor: 8.786

Review 5. Transarterial Chemoembolization for Hepatocellular Carcinoma: Why, When, How?

Authors: Evgenia Kotsifa; Chrysovalantis Vergadis; Michael Vailas; Nikolaos Machairas; Stylianos Kykalos; Christos Damaskos; Nikolaos Garmpis; Georgios D Lianos; Dimitrios Schizas
Journal: J Pers Med Date: 2022-03-10

5 in total